African American Treatment Advocacy Funding Available, May 14 Deadline

Glaxo Wellcome will fund "peer-based treatment advocacy initiatives designed to link HIV-positive African Americans to HIV treatment programs."

Proposals can be submitted from 501(c)3 organizations anywhere in the United States. These grants cannot be used to provide medications or medical treatment. Proposals must be received by the close of the business day Friday, May 14.

The following is from the Request for Proposals:


Objective
Glaxo Wellcome will fund peer-based treatment advocacy initiatives designed to link HIV-positive African Americans to HIV treatment programs. The number of grants and the amount of each grant will be determined during the proposed review process. Grant sizes may vary with a maximum of $30,000.
Criteria
Proposals may be submitted for new or existing/ongoing initiatives.
Proposals should focus specifically on the healthcare needs of HIV-positive African Americans and linking those individuals to HIV treatment programs.
Proposals may be submitted from any geographic location in the United States; both urban and non-urban areas desired.
Organizations submitting proposals must provide proof of 510(c)(3)status.
Organizations selected for funding may not use grant money to provide medications to treat HIV infection or to provide medical treatment for HIV.
Proposals must be received by close of business on May 14, 1999.
Application Process
Proposals should consist of a three- to five-page document describing the organization and the program/initiative designed to link HIV-positive African Americans to HIV treatment programs. The proposal must include the following information:
Project Description (e.g., project purpose/objective, scope of project, time period, budget, staff, results expected, intended audience, number of people to be served, setting/environment, project evaluation mechanism/clearly defined outcomes objectives).
Description of Organization (e.g., background, including length of time in existence, current and past funding sources, list of board of directors, how the program fits into the organization's overall mission and objectives, HIV-related medical services, if any, provided by organization).
Copy of 501(c)(3) Letter of Determination should be attached to the proposal.
Completed proposals may be mailed or faxed to:
Doris Campbell
Health Care Coalitions
Glaxo Wellcome Inc.
5 Moore Drive
Research Triangle Park, NC 27709
fax: 919-315-0062